Kim D Blickenstaff - Net Worth and Insider Trading

Kim D Blickenstaff Net Worth

The estimated net worth of Kim D Blickenstaff is at least $7 Million dollars as of 2024-12-27. Kim D Blickenstaff is the Director of Tandem Diabetes Care Inc and owns about 165,190 shares of Tandem Diabetes Care Inc (TNDM) stock worth over $6 Million. Kim D Blickenstaff is the Director of Medivation Inc and owns about 7,114 shares of Medivation Inc (MDVN) stock worth over $579,364. Kim D Blickenstaff is also the Director of Nuvation Bio Inc and owns about 172,189 shares of Nuvation Bio Inc (NUVB) stock worth over $485,573. Besides these, Kim D Blickenstaff also holds DexCom Inc (DXCM) . Details can be seen in Kim D Blickenstaff's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kim D Blickenstaff has not made any transactions after 2024-11-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kim D Blickenstaff

To

Kim D Blickenstaff Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kim D Blickenstaff owns 5 companies in total, including Tandem Diabetes Care Inc (TNDM) , Medivation Inc (MDVN) , and DexCom Inc (DXCM) among others .

Click here to see the complete history of Kim D Blickenstaff’s form 4 insider trades.

Insider Ownership Summary of Kim D Blickenstaff

Ticker Comapny Transaction Date Type of Owner
TNDM Tandem Diabetes Care Inc 2024-11-21 director & PRESIDENT AND CEO
MDVN Medivation Inc 2016-09-28 director
DXCM DexCom Inc 2006-03-13 director
LIMIT LIMIT 2024-06-11 director
LIMIT LIMIT 2021-10-26 director

Kim D Blickenstaff Latest Holdings Summary

Kim D Blickenstaff currently owns a total of 4 stocks. Among these stocks, Kim D Blickenstaff owns 165,190 shares of Tandem Diabetes Care Inc (TNDM) as of November 21, 2024, with a value of $6 Million and a weighting of 85.29%. Kim D Blickenstaff owns 7,114 shares of Medivation Inc (MDVN) as of November 21, 2013, with a value of $579,364 and a weighting of 8%. Kim D Blickenstaff also owns 172,189 shares of Nuvation Bio Inc (NUVB) as of June 11, 2024, with a value of $485,573 and a weighting of 6.71%. The other 1 stocks DexCom Inc (DXCM) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Kim D Blickenstaff

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TNDM Tandem Diabetes Care Inc 2024-11-21 165,190 37.37 6,173,150
MDVN Medivation Inc 2013-11-21 7,114 81.44 579,364
NUVB Nuvation Bio Inc 2024-06-11 172,189 2.82 485,573
DXCM DexCom Inc 2006-03-13 0 80.57 0

Holding Weightings of Kim D Blickenstaff


Kim D Blickenstaff Form 4 Trading Tracker

According to the SEC Form 4 filings, Kim D Blickenstaff has made a total of 21 transactions in Tandem Diabetes Care Inc (TNDM) over the past 5 years, including 0 buys and 21 sells. The most-recent trade in Tandem Diabetes Care Inc is the sale of 40,000 shares on November 21, 2024, which brought Kim D Blickenstaff around $1 Million.

According to the SEC Form 4 filings, Kim D Blickenstaff has made a total of 0 transactions in Medivation Inc (MDVN) over the past 5 years. The most-recent trade in Medivation Inc is the sale of 60,000 shares on November 21, 2013, which brought Kim D Blickenstaff around $2 Million.

According to the SEC Form 4 filings, Kim D Blickenstaff has made a total of 1 transactions in Nuvation Bio Inc (NUVB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Nuvation Bio Inc is the acquisition of 172,189 shares on June 11, 2024, which cost Kim D Blickenstaff around $499,348.

More details on Kim D Blickenstaff's insider transactions can be found in the Insider Trading History of Kim D Blickenstaff table.

Insider Trading History of Kim D Blickenstaff

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kim D Blickenstaff Trading Performance

GuruFocus tracks the stock performance after each of Kim D Blickenstaff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kim D Blickenstaff is 44.37%. GuruFocus also compares Kim D Blickenstaff's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kim D Blickenstaff within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kim D Blickenstaff's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kim D Blickenstaff

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.52 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 5.17 LIMIT LIMIT LIMIT LIMIT LIMIT

Kim D Blickenstaff Ownership Network

Ownership Network List of Kim D Blickenstaff

No Data

Ownership Network Relation of Kim D Blickenstaff

Insider Network Chart

Kim D Blickenstaff Owned Company Details

What does Tandem Diabetes Care Inc do?

Who are the key executives at Tandem Diabetes Care Inc?

Kim D Blickenstaff is the director & PRESIDENT AND CEO of Tandem Diabetes Care Inc. Other key executives at Tandem Diabetes Care Inc include SVP & General Counsel Shannon Marie Hansen , Senior Vice President and CFO Leigh Vosseller , and GENERAL COUNSEL David B Berger .

Tandem Diabetes Care Inc (TNDM) Insider Trades Summary

Over the past 18 months, Kim D Blickenstaff made 1 insider transaction in Tandem Diabetes Care Inc (TNDM) with a net sale of 40,000. Other recent insider transactions involving Tandem Diabetes Care Inc (TNDM) include a net sale of 0 shares made by Dick Allen , a net purchase of 6,200 shares made by Leigh Vosseller , and a net purchase of 1,935 shares made by Shannon Marie Hansen .

In summary, during the past 3 months, insiders sold 40,000 shares of Tandem Diabetes Care Inc (TNDM) in total and bought 532 shares, with a net sale of 39,468 shares. During the past 18 months, 45,000 shares of Tandem Diabetes Care Inc (TNDM) were sold and 14,667 shares were bought by its insiders, resulting in a net sale of 30,333 shares.

Tandem Diabetes Care Inc (TNDM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tandem Diabetes Care Inc Insider Transactions

No Available Data

Kim D Blickenstaff Mailing Address

Above is the net worth, insider trading, and ownership report for Kim D Blickenstaff. You might contact Kim D Blickenstaff via mailing address: C/o Medivation, Inc., 201 Spear Street, 3rd Floor, San Francisco Ca 94105.

Discussions on Kim D Blickenstaff

No discussions yet.